1 |
Leucine
| 1件: Leucine Leucine | 2件: L-leucine L-leucine; Leucine; | - | - | 6件: 6 6, 19, 65, 283, 284, 299 |
2 |
Levodopa
| 1件: Levodopa Levodopa | 9件: Carbidopa-Levodopa Carbidopa-Levodopa; DUODOPA; Inbrija; L-DOPA; Levodopa; PARCOPA; SINEMET; SINEMET CR; Stalevo; | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 17, 90, 140, 164, 201 |
3 |
Lactic acid
| 1件: Lactic acid Lactic acid | 1件: Lactic acid Lactic acid; | - | - | 1件: 299 299 |
4 |
Lactulose
| 1件: Lactulose Lactulose | 1件: Lactulose Lactulose; | - | - | 3件: 13 13, 96, 291 |
5 |
Lamivudine
| 1件: Lamivudine Lamivudine | 4件: COMBIVIR COMBIVIR; Epivir; Lamivudine; Triumeq; | - | - | 8件: 2 2, 26, 42, 46, 135, 256, 265, 325 |
6 |
Lamotrigine
| 1件: Lamotrigine Lamotrigine | 2件: Lamictal Lamictal; Lamotrigine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 13 13, 34, 38, 114, 144 |
7 |
Lansoprazole
| 1件: Lansoprazole Lansoprazole | 1件: Lansoprazole Lansoprazole; | 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 7件: 63 63, 71, 85, 98, 166, 222, 299 |
8 |
Lidocaine
| 1件: Lidocaine Lidocaine | 4件: Aloe Aloe; Lidocaine; Lignocaine; Xylocaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 13件: 6 6, 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 |
9 |
Lovastatin
| 1件: Lovastatin Lovastatin | 1件: Lovastatin Lovastatin; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 |
10 |
Lisinopril
| 1件: Lisinopril Lisinopril | 2件: Lisinopril Lisinopril; ZESTRIL; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 19 19, 46, 49, 66, 67, 113, 222 |
11 |
Loratadine
| 1件: Loratadine Loratadine | 2件: Loratadina Loratadina; Loratadine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 4件: 13 13, 46, 89, 98 |
12 |
Lorazepam
| 1件: Lorazepam Lorazepam | 1件: Lorazepam Lorazepam; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 36 36 |
13 |
Levofloxacin
| 1件: Levofloxacin Levofloxacin | 2件: Levaquin Levaquin; Levofloxacin; | - | - | 5件: 46 46, 53, 84, 85, 299 |
14 |
Levetiracetam
| 1件: Levetiracetam Levetiracetam | 2件: KEPPRA KEPPRA; Levetiracetam; | 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
15 |
Leflunomide
| 1件: Leflunomide Leflunomide | 3件: ARAVA ARAVA; Leflunomide; Leflunomidum; | 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 12件: 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 |
16 |
Lithium carbonate
| 1件: Lithium carbonate Lithium carbonate | 2件: Lithium Lithium; LITHIUM CARBONATE; | - | - | 5件: 2 2, 13, 17, 18, 127 |
17 |
Linezolid
| 1件: Linezolid Linezolid | 1件: LINEZOLID LINEZOLID; | - | - | 1件: 299 299 |
18 |
Levonorgestrel
| 1件: Levonorgestrel Levonorgestrel | 1件: LEVONORGESTREL LEVONORGESTREL; | 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
19 |
Letrozole
| 1件: Letrozole Letrozole | 1件: Letrozole Letrozole; | 1件: CYP19A1 CYP19A1 💬 | 3件: Metabolic pathways Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 2件: 81 81, 89 |
20 |
Lopinavir
| 1件: Lopinavir Lopinavir | 2件: Kaletra Kaletra; Lopinavir; | - | - | 2件: 93 93, 265 |
21 |
Levocarnitine
| 1件: Levocarnitine Levocarnitine | 4件: Carnitine Carnitine; L-Carnitine; LEVOCARNITINE; Xyzal; | - | - | 11件: 3 3, 5, 13, 53, 58, 86, 96, 97, 265, 298, 316 |
22 |
Lysine
| 1件: Lysine Lysine | 1件: Lysine Lysine; | - | - | 5件: 13 13, 19, 97, 228, 299 |
23 |
Limaprost
| 1件: Limaprost Limaprost | 1件: Limaprost Limaprost; | 1件: PTGER1 PTGER1 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | 1件: 70 70 |
24 |
Lactose
| 1件: Lactose Lactose | 1件: Lactose Lactose; | - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
25 |
Lenograstim
| 1件: Lenograstim Lenograstim | 2件: G-CSF G-CSF; Lenograstim; | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 7件: 2 2, 13, 16, 18, 19, 57, 65 |
26 |
Lactase
| 1件: Tilactase Tilactase | 1件: Beta-Galactosidase Beta-Galactosidase; | - | - | 1件: 19 19 |
27 |
Lumiracoxib
| 1件: Lumiracoxib Lumiracoxib | 1件: Lumiracoxib Lumiracoxib; | 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
28 |
Lactomin
| 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 4件: Acidophilus Acidophilus; Lacteol; Lactobacillus; Lactobacillus acidophilus; | - | - | 3件: 6 6, 49, 97 |
29 |
Lactobacillus casei
| 1件: Lactobacillus casei Lactobacillus casei | 2件: Fusion Fusion; Lactobacillus casei; | - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 |
30 |
Laronidase
| 1件: Laronidase Laronidase | 2件: Aldurazyme Aldurazyme; Laronidase; | 1件: IDUA IDUA 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 2件: 19 19, 256 |
31 |
Lecithin
| 1件: Lecithin Lecithin | 1件: Phosphatidylcholine Phosphatidylcholine; | - | - | 1件: 97 97 |
32 |
Lenalidomide
| 1件: Lenalidomide Lenalidomide | 2件: Lenalidomide Lenalidomide; REVLIMID; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 16 16, 26, 28, 34, 49, 284, 300, 331 |
33 |
Levosimendan
| 1件: Levosimendan Levosimendan | 1件: LEVOSIMENDAN LEVOSIMENDAN; | 2件: PDE3A PDE3A, PDE3B 💬 | 11件: Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
34 |
Liatermin
| 1件: Liatermin Liatermin | 2件: Liatermin Liatermin; R-metHuGDNF; | - | - | 1件: 6 6 |
35 |
Lithium citrate
| 1件: Lithium citrate Lithium citrate | 2件: Lithium Lithium; LITHIUM CITRATE; | - | - | 5件: 2 2, 5, 6, 7, 8 |
36 |
Lixivaptan
| 1件: Lixivaptan Lixivaptan | 1件: Lixivaptan Lixivaptan; | 1件: AVPR2 AVPR2 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 67 67 |
37 |
Lonafarnib
| 1件: Lonafarnib Lonafarnib | 1件: Lonafarnib Lonafarnib; | 2件: FNTA FNTA, FNTB 💬 | 1件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis 💬 | 2件: 113 113, 333 |
38 |
Lubiprostone
| 1件: Lubiprostone Lubiprostone | 1件: Lubiprostone Lubiprostone; | 1件: CLCN2 CLCN2 💬 | 1件: Mineral absorption Mineral absorption 💬 | 4件: 6 6, 13, 290, 299 |
39 |
Lucinactant
| 1件: Lucinactant Lucinactant | 1件: Lucinactant Lucinactant; | - | - | 1件: 299 299 |
40 |
Liraglutide
| 1件: Liraglutide Liraglutide | 2件: Liraglutide Liraglutide; Saxenda; | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 75, 193 |
41 |
Lacosamide
| 1件: Lacosamide Lacosamide | 1件: Lacosamide Lacosamide; | 2件: SCN3A SCN3A, SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 |
42 |
Levocetirizine
| 1件: Levocetirizine Levocetirizine | 1件: Levocetirizina Levocetirizina; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
43 |
Lapatinib
| 1件: Lapatinib Lapatinib | 1件: Lapatinib Lapatinib; | 2件: EGFR EGFR, ERBB2 💬 | 50件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬 | 3件: 34 34, 74, 75 |
44 |
Levamisole
| 1件: Levamisole Levamisole | 1件: Levamisole Levamisole; | - | - | 4件: 60 60, 61, 62, 222 |
45 |
Levobupivacaine
| 1件: Levobupivacaine Levobupivacaine | 2件: Bupivacaine Bupivacaine; Levobupivacaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 46 46 |
46 |
Levofloxacin
| 1件: Levofloxacin Levofloxacin | 2件: Levaquin Levaquin; Levofloxacin; | - | - | 5件: 46 46, 53, 84, 85, 299 |
47 |
Levosalbutamol
| 1件: Levosalbutamol Levosalbutamol | 2件: R-salbutamol R-salbutamol; Salbutamol; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 49 49 |
48 |
Levothyroxine
| 1件: Levothyroxine Levothyroxine | 2件: Levothyroxine Levothyroxine; Thyroxine; | 2件: THRA THRA, THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 5件: 19 19, 49, 78, 80, 222 |
49 |
Lidocaine hydrochloride monohydrate
| 1件: Lidocaine Lidocaine | 4件: Aloe Aloe; Lidocaine; Lignocaine; Xylocaine; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 13件: 6 6, 13, 22, 34, 46, 51, 70, 84, 86, 107, 168, 226, 256 |
50 |
Liothyronine
| 1件: Liothyronine Liothyronine | 3件: Liothyronine Liothyronine; Liothyronine sodium; Triiodothyronine; | 2件: THRA THRA, THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 4件: 13 13, 78, 210, 212 |
51 |
Lisdexamfetamine
| 1件: Lisdexamfetamine Lisdexamfetamine | 1件: Lisdexamfetamine Lisdexamfetamine; | 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
52 |
Lisinopril
| 1件: Lisinopril Lisinopril | 2件: Lisinopril Lisinopril; ZESTRIL; | 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 7件: 19 19, 46, 49, 66, 67, 113, 222 |
53 |
Lisuride
| 1件: Lisuride Lisuride | 1件: Lisuride Lisuride; | 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
54 |
Loperamide
| 1件: Loperamide Loperamide | 2件: Loperamide Loperamide; Loperamide hydrochloride; | 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 13 13, 97 |
55 |
Losartan
| 1件: Losartan Losartan | 3件: Cozaar Cozaar; Losartan; Losartan Potassium; | 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
56 |
Loxoprofen
| 1件: Loxoprofen Loxoprofen | 1件: Loxoprofen Loxoprofen; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
57 |
Levomefolic acid
| 1件: Levomefolic acid Levomefolic acid | 1件: L-methylfolate L-methylfolate; | - | - | 2件: 6 6, 201 |
58 |
Linaclotide
| 1件: Linaclotide Linaclotide | 1件: Linaclotide Linaclotide; | 1件: GUCY2C GUCY2C 💬 | 2件: Metabolic pathways Metabolic pathways, Purine metabolism 💬 | 2件: 6 6, 97 |
59 |
Lebrikizumab
| 1件: Lebrikizumab Lebrikizumab | 1件: LEBRIKIZUMAB LEBRIKIZUMAB; | 1件: IL13 IL13 💬 | 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 85 85 |
60 |
Lomitapide
| 1件: Lomitapide Lomitapide | 2件: Lojuxta Lojuxta; LOMITAPIDE; | 1件: MTTP MTTP 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 79 79 |
61 |
Losmapimod
| 1件: Losmapimod Losmapimod | 1件: Losmapimod Losmapimod; | 4件: MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 2件: 113 113, 222 |
62 |
Lixisenatide
| 1件: Lixisenatide Lixisenatide | 1件: Lixisenatide Lixisenatide; | 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
63 |
Latrepirdine
| 1件: Latrepirdine Latrepirdine | 2件: Dimebon Dimebon; Latrepirdine; | 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
64 |
Linsitinib
| 1件: Linsitinib Linsitinib | 1件: Linsitinib Linsitinib; | 1件: IGF1R IGF1R 💬 | 29件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 232 232 |
65 |
Lumacaftor
| 1件: Lumacaftor Lumacaftor | 2件: LUMACAFTOR LUMACAFTOR; Orkambi; | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
66 |
Ledipasvir
| 1件: Ledipasvir Ledipasvir | 1件: Ledipasvir Ledipasvir; | - | - | 1件: 19 19 |
67 |
Letermovir
| 1件: Letermovir Letermovir | 1件: Letermovir Letermovir; | - | - | 1件: 85 85 |
68 |
Levoketoconazole
| 1件: Levoketoconazole Levoketoconazole | 1件: Levoketoconazole Levoketoconazole; | 3件: CYP11A1 CYP11A1, CYP11B1, CYP17A1 💬 | 7件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
69 |
Leniolisib
| 1件: Leniolisib Leniolisib | 1件: Leniolisib Leniolisib; | 3件: PIK3CA PIK3CA, PIK3CB, PIK3CD 💬 | 106件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 2件: 53 53, 65 |
70 |
Lenabasum
| 1件: Ajulemic acid Ajulemic acid | 1件: Ajulemic acid Ajulemic acid; | 1件: CNR2 CNR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 50 50, 51, 299 |
71 |
Lucerastat
| 1件: Lucerastat Lucerastat | 1件: Lucerastat Lucerastat; | 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
72 |
Lonapegsomatropin
| 1件: Lonapegsomatropin Lonapegsomatropin | 1件: LONAPEGSOMATROPIN LONAPEGSOMATROPIN; | 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
73 |
Lanraplenib
| 1件: Lanraplenib Lanraplenib | 1件: Lanraplenib Lanraplenib; | - | - | 2件: 53 53, 222 |
74 |
Leriglitazone
| 1件: Leriglitazone Leriglitazone | 1件: Leriglitazone Leriglitazone; | 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 20 20 |
75 |
Lefamulin
| 1件: Lefamulin Lefamulin | 1件: Lefamulin Lefamulin; | - | - | 1件: 299 299 |
76 |
Luspatercept
| 1件: Luspatercept Luspatercept | 1件: Luspatercept Luspatercept; | 1件: ACVR2B ACVR2B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | 1件: 60 60 |
77 |
Lirentelimab
| 1件: Lirentelimab Lirentelimab | 1件: Lirentelimab Lirentelimab; | 1件: SIGLEC8 SIGLEC8 💬 | - | 1件: 98 98 |
78 |
Lumasiran
| 1件: Lumasiran Lumasiran | 1件: LUMASIRAN LUMASIRAN; | 1件: HAO1 HAO1 💬 | 4件: Carbon metabolism Carbon metabolism, Glyoxylate and dicarboxylate metabolism, Metabolic pathways, Peroxisome 💬 | 1件: 234 234 |
79 |
Latozinemab
| 1件: Latozinemab Latozinemab | 2件: AL001 AL001; Latozinemab; | 1件: SORT1 SORT1 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬 | 2件: 2 2, 127 |